Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H14ClN3O4S3 |
| Molecular Weight | 383.895 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=C(Cl)C=C2NC(CSCC=C)NS(=O)(=O)C2=C1
InChI
InChIKey=VGLGVJVUHYTIIU-UHFFFAOYSA-N
InChI=1S/C11H14ClN3O4S3/c1-2-3-20-6-11-14-8-4-7(12)9(21(13,16)17)5-10(8)22(18,19)15-11/h2,4-5,11,14-15H,1,3,6H2,(H2,13,16,17)
| Molecular Formula | C11H14ClN3O4S3 |
| Molecular Weight | 383.895 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. | 2010-04 |
|
| Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. | 2009-09-15 |
|
| Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. | 2009-03-20 |
|
| Stability of selected chlorinated thiazide diuretics. | 2009-02-20 |
|
| A case of brucellar spondylodiscitis involving the cervical spine. | 2009 |
|
| Mechanism of [m+h]+ formation in atmospheric pressure photoionization mass spectrometry: identification of propionitrile in acetonitrile with high mass accuracy measurement and tandem mass spectrometry and evidence for its involvement in the protonation phenomenon. | 2008-11 |
|
| Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis. | 2006-12-01 |
|
| High-speed gas chromatography in doping control: fast-GC and fast-GC/MS determination of beta-adrenoceptor ligands and diuretics. | 2006-12 |
|
| Synthesis and application of mono-2A-azido-2A-deoxyperphenylcarbamoylated beta-cyclodextrin and mono-2A-azido-2A-deoxyperacetylated beta-cyclodextrin as chiral stationary phases for high-performance liquid chromatography. | 2006-01-06 |
|
| Effects of pH and the presence of micelles on the resolution of diuretics by reversed-phase liquid chromatography. | 2004-01-02 |
|
| [Management of bronchiolitis in the infant. Recommendations. Long text]. | 2001-01 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2191585
Aldactazine ( 25 mg spironolactone and 15 mg altizide, 1/day)
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:02 GMT 2025
by
admin
on
Mon Mar 31 18:22:02 GMT 2025
|
| Record UNII |
GI8CB72B0D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QC03EA04
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
||
|
NCI_THESAURUS |
C49185
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
||
|
WHO-ATC |
C03EA04
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB05379MIG
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
m1584
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
2122
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL599870
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
1382
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
17599
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
140
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
DTXSID3045857
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
5588-16-9
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
226-994-8
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
GI8CB72B0D
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
757786
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
100000092140
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
C80838
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
C006480
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY | |||
|
ALTIZIDE
Created by
admin on Mon Mar 31 18:22:02 GMT 2025 , Edited by admin on Mon Mar 31 18:22:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE |
|
||
|
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|